USEUROPEAFRICAASIA 中文双语Français
Home / Business

Novo Nordisk aims to double R&D staff

By Liu Jie | China Daily | Updated: 2010-09-15 07:51

Novo Nordisk aims to double R&D staff

Jesper Brandgaard, CFO of Novo Nordisk

BEIJING - Diabetes-focused pharmaceutical company Novo Nordisk plans to double its research and development (R&D) capability in China within three to five years, to meet demand in its fastest-growing market and develop tailored solutions for Chinese over the longer term.

Novo Nordisk aims to double R&D staff

Today's Top News

Editor's picks

Most Viewed

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US